Research Recommendations For GE HealthCare Technologies Inc (GEHC): Here is What You Should Know

GE HealthCare Technologies Inc (NASDAQ:GEHC) saw a downside of -0.41% to close Tuesday at $66.21 after subtracting -$0.27 on the day. The 5-day average trading volume is 2,617,060 shares of the company’s common stock. It has gained $67.40 in the past week and touched a new high 3 times within the past 5 days. An average of 3,109,495 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,103,702.

GEHC’s 1-month performance is -3.47% or -$2.38 on its low of $63.74 reached on 09/22/23. The company’s shares have touched a 52-week low of $53.00 and high of $87.83. YTD, GEHC has achieved 13.41% or $7.83 and has reached a new high 25 times. However, the current price is down -24.62% from the 52-week high price.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Insider Transactions

GEHC stock investors last saw insider trading activity on Jul 31.O’Neill Kevin Michael (CEO, PDx) most recently sold 15,609 shares at $77.32 per share on Jul 31. This transaction cost the insider $1,206,949. CEO, Ultrasound, Rott Roland, sold 2,473 shares at a price of $77.37 on Jun 08. Then, on Mar 14, CEO, Imaging Makela Jan sold 70,629 shares at a price of $77.69 per share. This transaction amounted to $5,487,379.

Valuation Metrics

Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 4.24.

GE HealthCare Technologies Inc’s quick ratio for the period ended June 29 was 0.87, with the current ratio over the same period at 1.17. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.44, while the total debt to equity was 1.49. The trailing 12-month EBITDA margin is 17.43%. The firm’s gross profit as reported stood at $7.18 billion against revenue of $18.34 billion.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 100.0% to $418.0 million, while revenue of $189.0 million was 54.78% off the previous quarter. Analysts expected GEHC to announce $0.87 per share in earnings in its latest quarter, but it posted $0.92, representing a 5.70% surprise. EBITDA for the quarter stood at more than $726.0 million. GEHC stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 25.2 billion, with total debt at $10.61 billion. Shareholders hold equity totaling $454.84 million.

Let’s look briefly at GE HealthCare Technologies Inc (GEHC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 26 September was 48.56% to suggest the stock is trending Neutral, with historical volatility in this time period at 24.82%.

The stock’s 5-day moving average is $65.18, reflecting a +0.14% or $0.09 change from its current price. GEHC is currently trading -4.47% above its 20-day SMA, -16.94% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -18.45%.

Stochastic %K and %D was 42.74% and 25.10% and the average true range (ATR) pointed at 1.59. The RSI (14) points at 43.49%, while the 14-day stochastic is at 55.79% with the period’s ATR at 1.57. The stock’s 9-day MACD Oscillator is pointing at 0.03 and 0.09 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for GE HealthCare Technologies Inc (NASDAQ: GEHC), Citigroup launched coverage with a Buy rating. Analysts offering their rating for GEHC stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate GEHC as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 8 have offered a “buy” rating.

What is GEHC’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $78.00 and a high of $99.00, with their median price target at $89.00. Looking at these predictions, the average price target given by analysts is for GE HealthCare Technologies Inc (GEHC) stock is $88.90.

Most Popular

Related Posts